Effects of coagulation factor XIII on intestinal functional capillary density, leukocyte adherence and mesenteric plasma extravasation in experimental endotoxemia

被引:14
作者
Birnbaum, Juergen
Hein, Ortrud Vargas
Luehrs, Carsten
Rueckbeil, Oskar
Spies, Claudia
Ziemer, Sabine
Gruendling, Matthias
Usichenko, Taras
Meissner, Konrad
Pavlovic, Dragan
Kox, Wolfgang J.
Lehmann, Christian
机构
[1] Charite Univ Med Berlin, Klin Anaesthesiol & Operat Intens Med, D-10117 Berlin, Germany
[2] Charite Univ Med Berlin, Inst Lab Med & Pathobiochem, D-10117 Berlin, Germany
[3] Ernst Moritz Arndt Univ Greifswald, Klin Anasthesiol & Intens Med, D-17489 Greifswald, Germany
来源
CRITICAL CARE | 2006年 / 10卷 / 01期
关键词
D O I
10.1186/cc3994
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Introduction The objective of this study was to determine the effects of the administration of the coagulation factor XIII ( F XIII) on intestinal functional capillary density, leukocyte adherence and mesenteric plasma extravasation during experimental endotoxemia. Methods In a prospective, randomized, controlled animal study 42 male Wistar rats were divided into three groups. Group 1 served as the control group. Groups 2 ( lipopolysaccharide (LPS) group) and 3 ( F XIII group) received endotoxin infusions (2.5 mg/kg/h for 2 hours). In group 3, 50 U/kg body weight F XIII was continuously administered during the first 30 minutes of endotoxemia. F XIII levels were measured in all animals. One half of the animals of each group were studied for intestinal functional capillary density (FCD) and leukocyte adherence on venular endothelium by intravital fluorescence microscopy (IVM). In the other half of each group, mesenteric plasma extravasation (FITC-albumin) was determined by IVM. Results The F XIII level was significantly increased in the F XIII treatment group. In the LPS group, endotoxemia led to a significant reduction of mucosal FCD (- 18.5%; p < 0.01 versus control group). F XIII administration in the F XIII group attenuated the decrease in mucosal FCD (- 3.7% compared to control; p < 0.05 versus LPS group). During endotoxemia, a significant increase of leukocyte adherence at the endothelium could be noted in the LPS group compared to the control group. Leukocyte adherence at the endothelium and plasma extravasation in the F XIII group did not differ significantly from the LPS group. Conclusion Factor XIII protected mucosal capillary perfusion against endotoxin-induced impairment in an experimental sepsis model in rats, whereas leukocyte adherence and plasma extravasation remained unchanged.
引用
收藏
页数:7
相关论文
共 35 条
[11]   The effect of fibrin stabilizing factor (F.XIII) on healing of bone defects in normal and uncontrolled diabetic rats [J].
El-Hakim, IE .
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 1999, 28 (04) :304-308
[12]   MICROVASCULAR PRESSURES IN RAT INTESTINAL MUSCLE AND MUCOSAL VILLI [J].
GORE, RW ;
BOHLEN, HG .
AMERICAN JOURNAL OF PHYSIOLOGY, 1977, 233 (06) :H685-H693
[13]   SUPPRESSIVE EFFECT OF HUMAN BLOOD-COAGULATION FACTOR-XIII ON THE VASCULAR-PERMEABILITY INDUCED BY ANTI-GUINEA-PIG ENDOTHELIAL-CELL ANTISERUM IN GUINEA-PIGS [J].
HIRAHARA, K ;
SHINBO, K ;
TAKAHASHI, M ;
MATSUISHI, T .
THROMBOSIS RESEARCH, 1993, 71 (02) :139-148
[14]   DEGRADATION OF HUMAN-PLASMA FIBRIN STABILIZING FACTOR-XIII SUBUNITS BY HUMAN GRANULOCYTIC PROTEINASES [J].
KLINGEMANN, HG ;
EGBRING, R ;
HOLST, F ;
GRAMSE, M ;
HAVEMANN, K .
THROMBOSIS RESEARCH, 1982, 28 (06) :793-801
[15]   Depletion of plasma factor XIII prevents disseminated intravascular coagulation-induced organ damage [J].
Lee, SY ;
Chang, SK ;
Lee, IH ;
Kim, YM ;
Chung, SI .
THROMBOSIS AND HAEMOSTASIS, 2001, 85 (03) :464-469
[16]   FACTOR-XIII SUBSTITUTION IN ULCERATIVE-COLITIS [J].
LORENZ, R ;
BORN, P ;
OLBERT, P ;
CLASSEN, M .
LANCET, 1995, 345 (8947) :449-450
[17]  
Marzano AV, 2000, EUR J DERMATOL, V10, P14
[18]   MICROVASCULAR ISCHEMIA-REPERFUSION INJURY IN STRIATED-MUSCLE - SIGNIFICANCE OF NO REFLOW [J].
MENGER, MD ;
STEINER, D ;
MESSMER, K .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (06) :H1892-H1900
[19]  
MOSHER DF, 1991, ANN NY ACAD SCI, V614, P167
[20]   Blood coagulation factor XIII: Structure and function [J].
Muszbek, L ;
Yee, VC ;
Hevessy, Z .
THROMBOSIS RESEARCH, 1999, 94 (05) :271-305